DMBIO

DM Bio is a biopharmaceutical manufacturing company which is located in Incheon, South Korea. 
Dong-A Socio Holdings, the No. 1 Korean pharmaceutical company, and Meiji Seika Pharma which has advanced R&D capabilities and know-how from Japan, jointly established DM Bio.

We are committed to leading our clients' projects successfully by providing H
igh Quality Products and Exquisite Service.


  • Maximizing Production Efficiency through Hybrid System
  • Multiple Independent Production Lines for mAb and Recombinant Proteins  
  • Non-GMP and GMP manufacturing facility lines for efficient process development and technology transfer
  • Initial process development in the early stage through the scale-down validation studies at small scale
  • Complying with Global Guidelines
  • Experts with experience from R&D and cGMP facility
Is this your Organization?   Request Access

Locations


Korea (South) (Republic)
Incheon Korea
45 DM Bio, Jisikgiban-ro,Yeonsu-gu
Incheon,   406-840
Korea (South) (Republic), Asia

Contacts


Jin Pub SON
Business Development team
DONG-WOO SHIN
Business Development Team(日本語対応可能)
Edison Tong Zhu
Business Development Team(中文担当者)
Geum-lan Bae
Business Development Team

Production Lines

Incheon Korea   Production Line1
Location: Incheon, Korea (South) (Republic)
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Scale:  2000L-5000L2500L Bioreactor
GMP Level:  CommercialCommercial
Biosafety Level:  Not SpecifiedNot Specified
Single Use:  Bioreactor OnlyBioreactor Only
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is Not AvailableCell Banking
Cell Line Development is Not AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is AvailableViral Manufacturing
Availability: Available

Last Update: 02NOV14

Send Inquiry about this Production Line
Incheon Korea   Production Line2
Location: Incheon, Korea (South) (Republic)
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Scale:  2000L-5000L2500L Bioreactor
GMP Level:  CommercialCommercial
Biosafety Level:  Not SpecifiedNot Specified
Single Use:  Bioreactor OnlyBioreactor Only
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is Not AvailableCell Banking
Cell Line Development is Not AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is AvailableViral Manufacturing
Availability: Available

Last Update: 02NOV14

Send Inquiry about this Production Line
Incheon Korea   Production Line 3
Location: Incheon, Korea (South) (Republic)
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Scale:  2000L-5000L2500L Bioreactor
GMP Level:  CommercialCommercial
Biosafety Level:  Not SpecifiedNot Specified
Single Use:  Bioreactor OnlyBioreactor Only
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is Not AvailableCell Banking
Cell Line Development is Not AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is AvailableViral Manufacturing
Availability: Available

Last Update: 02NOV14

Send Inquiry about this Production Line
Incheon Korea   Production Line 4
Location: Incheon, Korea (South) (Republic)
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Scale:  100L-2000L500L Bioreactor
GMP Level:  CommercialCommercial
Biosafety Level:  Not SpecifiedNot Specified
Single Use:  AllAll
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is Not AvailableCell Banking
Cell Line Development is Not AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is AvailableViral Manufacturing
Availability: Available

Last Update: 02NOV14

Send Inquiry about this Production Line
Incheon Korea   Prefilled Syringe Line
Location: Incheon, Korea (South) (Republic)
Main Details
Specialization:  Drug Product (Fill/Finish)Drug Product (Fill/Finish)
Dosage Form:  LiquidLiquid
Batch Size:  1-5,0001-5,000
GMP Level:  CommercialCommercial
Biosafety Level:  Not SpecifiedNot Specified
Additional Services
Analytical Services are AvailableAnalytical Services
Formulation Development is Not AvailableFormulation Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Stability Studies are AvailableStability Studies
Prefilled Syringes are AvailablePrefilled Syringes
Viral Manufacturing is AvailableViral Manufacturing
Availability: Not Available

Last Update: 28OCT14

Send Inquiry about this Production Line

Copyright © Kymanox, All Rights Reserved.